Calcitonin
Visin, A.N.
Klinicheskaia Meditsina 65(1): 37-43
1987
ISSN/ISBN: 0023-2149 PMID: 3550281 Document Number: 300091
Document emailed within 1 workday
Related Documents
Ziegler, R.; Raue, F. 1984: Variations of plasma calcitonin levels measured by radioimmunoassay systems for human calcitonin Biomedicine and PharmacoTherapy 38(5): 245-251Yiin, K.T.; Chiang, C.D.; Chen, C.F.; Wang, S.J.; Lin, W.H.; Guu, C.J.; Lee, H.K.; Jih, K.S.; Lin, T.M.; Huang, W.L. 1987: The serum levels of human calcitonin (hCT) and salmon calcitonin (sCT) in lung cancer patients Zhonghua Yi Xue Za Zhi 40(6): 517-522
Suva, L.J.; Flannery, M.S.; Caulfield, M.P.; Findlay, D.M.; Jüppner, H.; Goldring, S.R.; Rosenblatt, M.; Chorev, M. 1997: Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor Journal of Pharmacology and Experimental Therapeutics 283(2): 876-884
Dopplet, S.H.; Talmage, R.V. 1976: Calcitonin and the bone fluid compartment: effect of calcitonin and/or parathyroid hormone on plasma radiocalcium changes Clinical Orthopaedics and Related Research 118: 242-250
Saller, B.; Goerges, R.; Reinhardt, W.; Haupt, K.; Janssen, O.E.; Mann, K. 2002: Sensitive Calcitonin Measurement by Two-site Immunometric Assays: Implications for Calcitonin Screening in Nodular Thyroid Disease Clinical Laboratory 48(3-4): 191-200
Galán Galán, F.; Garrido Peralta, M. 1982: Calcitonin as a tumor marker. II. Calcitonin in non-thyroid tumors Revista Clinica Espanola 165(2): 73-76
Lamari, Y.; Tahri, E.H.; Collignon, H.; Garel, J.M. 1994: Steroid hormones and retinoic acid interact in the regulation of calcitonin and calcitonin gene-related peptide secretion and messenger ribonucleic acid levels in CA-77 C cells Cellular and Molecular Biology 40(4): 541-550
Szücs, J.; Steczek, K. 1978: Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis Orvosi Hetilap 119(20): 1220-1224
Miyashita, Y.; Morimoto, S.; Ogihara, T.; Kumahara, Y. 1990: Calcitonin Nihon Rinsho. Japanese Journal of Clinical Medicine 48(12): 2791-2796
Heynen, G. 1978: Calcitonin: its therapeutic use Bruxelles Medical 58(3): 137-139
Kubović, J. 1980: First experience with the use of calcitonin Reumatizam 27(2): 46-47
Falch, J. 1979: Treatment with calcitonin Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 99(22): 1007-1008
Nagasaki, T.; Inaba, M. 2005: Calcitonin, procalcitonin Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 295-299
Menczel, J. 1970: Human calcitonin Harefuah 78(3): 129-130
Kuhlencordt, F. 1987: Calcitonin in osteoporosis Deutsche Medizinische Wochenschrift 112(31-32): 1235
Procházka, Z. 1985: Calcitonin. 1. Chemistry and physiology Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 52(2): 95-100
Andersson, D.E.; Kallner, G. 1975: The use of calcitonin as exemplified by 2 cases Lakartidningen 72(48): 4729-4730
Yasuda, S.; Ono, K.; Wada, S. 2005: Calcitonin actions on kidney Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 10): 207-210
Wasylewski, A. 1976: Ectopic secretion of calcitonin Polski Tygodnik Lekarski 31(15): 637-638
Spigset, O.; Mjörndal, T.; Vinge, E.; Lerner, U.H. 1993: Calcitonin as medication in pain? Nordisk Medicin 108(2): 54-57